Spirit Small Vessel Registry (SPIRIT SV).
Phase of Trial: Phase III
Latest Information Update: 06 Nov 2014
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms SPIRIT SV
- Sponsors Abbott Laboratories
- 07 Jun 2017 Biomarkers information updated
- 31 Oct 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 May 2012 Planned End Date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.